Blog
Federal Circuit Evaluates Enablement for Antibody Claims for the First Time Since Amgen v. Sanofi in Baxalta Inc. et al. v. Genentech, Inc.
Read moreTTAB Rules Consumer Perception Remains the Critical Inquiry for Generic.gTLD Marks
ITC Monthly Wrap-Up: August 2023
Legal Alert: USPTO Warns Trademark Applicants to Beware of Spoofed Calls
Minnesota Patent Litigation Wrap-Up: Q2 2023
ITC Monthly Wrap-Up: July 2023
Texas Patent Litigation Monthly Wrap-Up: June 2023
ITC Monthly Wrap-Up: June 2023
How to Minimise Preliminary Injunction Risk in the UPC
Now Is the Time to Step Up for the LGBTQ+ Community